John G. Frelinger, Ph.D.

John G. Frelinger, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Journal Articles

Showing all 85 journal articles available.

2013 Jun
Gerber SA, Sedlacek AL, Cron KR, Murphy SP, Frelinger JG, Lord EM. "IFN-? mediates the antitumor effects of radiation therapy in a murine colon tumor." The American journal of pathology. 2013 Jun; 182(6):2345-54. Epub 2013 Apr 12.
2013 Mar
Gerber SA, Sorensen EW, Sedlacek AL, Lim JY, Skrombolas D, Frelinger JG, Lord EM. "Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy." Immunology. 2013 Mar; 138(3):280-92.
2011 Jun
Puskas J, Skrombolas D, Sedlacek A, Lord E, Sullivan M, Frelinger J. "Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases." Immunology. 2011 Jun; 133(2):206-20. Epub 2011 Mar 23.
2011 Mar
Valentino MD, Maben ZJ, Hensley LL, Woolard MD, Kawula TH, Frelinger JA, Frelinger JG. "Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets." Immunology. 2011 Mar; 132(3):348-60. Epub 2011 Jan 07.
2011
Valentino M.D.; Abdul-Alim C.S.; Maben Z.J.; Skrombolas D., Hensley L.L.; Kawula T.H.; Dziejman M.; Lord E.M.; Frelinger J.A.; Frelinger J.G. "A broadly applicable approach to T cell epitope identification: Application to improving tumor associated epitopes and identifying epitopes in complex pathogens". Journal of Immunological Methods (in press). 2011; .
2010 Feb 15
Sorensen EW, Gerber SA, Frelinger JG, Lord EM. "IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms." The Journal of immunology : official journal of the American Association of Immunologists. 2010 Feb 15; 184(4):1858-66. Epub 2010 Jan 08.
2009 May
Valentino MD, Hensley LL, Skrombolas D, McPherson PL, Woolard MD, Kawula TH, Frelinger JA, Frelinger JG. "Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS." Molecular immunology. 2009 May; 46(8-9):1830-8. Epub 2009 Feb 23.
2009
Valentino M, Frelinger J. "An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis." Immunologic research. 2009 45(2-3):218-28. Epub 2009 Feb 11.
2008 Mar 1
Lugade AA, Sorensen EW, Gerber SA, Moran JP, Frelinger JG, Lord EM. "Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity." The Journal of immunology : official journal of the American Association of Immunologists. 2008 Mar 1; 180(5):3132-9.
2007 Apr 30
Malboeuf CM, Simon DA, Lee YE, Lankes HA, Dewhurst S, Frelinger JG, Rose RC. "Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo." Vaccine. 2007 Apr 30; 25(17):3270-6. Epub 2007 Jan 22.
2007 Feb 19
Santos K, Duke CM, Rodriguez-Colon SM, Dakwar A, Fan S, Keefer MC, Federoff HJ, Frelinger JG, Bowers WJ, Dewhurst S. "Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag." Vaccine. 2007 Feb 19; 25(9):1634-46. Epub 2006 Nov 15.
2007 Feb
Santos K, Simon DA, Conway E, Bowers WJ, Mitra S, Foster TH, Lugade A, Lord EM, Federoff HJ, Dewhurst S, Frelinger JG. "Spatial and temporal expression of herpes simplex virus type 1 amplicon-encoded genes: implications for their use as immunization vectors." Human gene therapy. 2007 Feb; 18(2):93-105.
2007 Jan 27
Ramanayake T, Simon DA, Frelinger JG, Lord EM, Robert J. "In vivo study of T-cell responses to skin alloantigens in Xenopus using a novel whole-mount immunohistology method." Transplantation. 2007 Jan 27; 83(2):159-66.
2006 Nov
Gerber SA, Rybalko VY, Bigelow CE, Lugade AA, Foster TH, Frelinger JG, Lord EM. "Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth." The American journal of pathology. 2006 Nov; 169(5):1739-52.
2006 Feb
Wagner VE, Frelinger JG, Barth RK, Iglewski BH. "Quorum sensing: dynamic response of Pseudomonas aeruginosa to external signals." Trends in microbiology. 2006 Feb; 14(2):55-8. Epub 2006 Jan 06.
2006
Mitra S, Cassar SE, Niles DJ, Puskas JA, Frelinger JG, Foster TH. "Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1alpha." Molecular cancer therapeutics. 2006 5(12):3268-74.
2005 Jun 15
Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. "Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor." The Journal of immunology : official journal of the American Association of Immunologists. 2005 Jun 15; 174(12):7516-23.
2005 May 1
Gerber SA, Turner MJ, Lugade AA, Moran JP, Frelinger JG, Lord EM. "Characterization of a lymph node within the mouse prostate: Detailed analysis using whole mount histology." The Prostate. 2005 May 1; 63(2):105-16.
2004 Jul
Bigelow CE, Vishwasrao HD, Frelinger JG, Foster TH. "Imaging enzyme activity with polarization-sensitive confocal fluorescence microscopy." Journal of microscopy. 2004 Jul; 215(Pt 1):24-33.
2003 Sep 20
Moran JP, Gerber SA, Martin CA, Frelinger JG, Lord EM. "Transfection of the genes for interleukin-12 into the K1735 melanoma and the EMT6 mammary sarcoma murine cell lines reveals distinct mechanisms of antitumor activity." International journal of cancer. Journal international du cancer. 2003 Sep 20; 106(5):690-8.
2003 May 6
Gerber SA, Moran JP, Frelinger JG, Frelinger JA, Fenton BM, Lord EM. "Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts." British journal of cancer. 2003 May 6; 88(9):1453-61.
2003
Mitra S, Goren EM, Frelinger JG, Foster TH. "Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo." Photochemistry and photobiology. 2003 78(6):615-22.
2002 May 15
Fisher TL, Nocera M, Willis RA, Turner MJ, Abdul Alim CS, Brown DM, Bourne PA, di Sant'Agnese PA, Messing EM, Lord EM, Frelinger JG. "Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors." The Prostate. 2002 May 15; 51(3):153-65.
2001 Nov
Patel D, Frelinger J, Goudsmit J, Kim B. "In vitro assay for site-specific proteases using bead-attached GFP substrate." BioTechniques. 2001 Nov; 31(5):1194, 1196, 1198 passim.
2001 Oct 10
Willis RA, Bowers WJ, Turner MJ, Fisher TL, Abdul-Alim CS, Howard DF, Federoff HJ, Lord EM, Frelinger JG. "Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice." Human gene therapy. 2001 Oct 10; 12(15):1867-79.
2001 Oct 1
Turner MJ, Abdul-Alim CS, Willis RA, Fisher TL, Lord EM, Frelinger JG. "T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes." Journal of immunological methods. 2001 Oct 1; 256(1-2):107-19.
2001 Apr
Brown DM, Fisher TL, Wei C, Frelinger JG, Lord EM. "Tumours can act as adjuvants for humoral immunity." Immunology. 2001 Apr; 102(4):486-97.
2001
Skrincosky D, Willis RA, Hocknell PK, Frelinger JG, Mirandola P, Wang X, Dewhurst S. "Epitope mapping of human herpesvirus-7 gp65 using monoclonal antibodies." Archives of virology. 2001 146(9):1705-22.
2000 Feb
Lee J, Moran JP, Fenton BM, Koch CJ, Frelinger JG, Keng PC, Lord EM. "Alteration of tumour response to radiation by interleukin-2 gene transfer." British journal of cancer. 2000 Feb; 82(4):937-44.
2000 Jan 13
Conway TF, Sabel MS, Sugano M, Frelinger JG, Egilmez NK, Chen F, Bankert RB. "Growth of human tumor xenografts in SCID mice quantified using an immunoassay for tumor marker protein in serum." Journal of immunological methods. 2000 Jan 13; 233(1-2):57-65.
1999 Jun 1
Martin BK, Frelinger JG, Ting JP. "Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growth." The Journal of immunology : official journal of the American Association of Immunologists. 1999 Jun 1; 162(11):6663-70.
1999 May
Storozynsky E, Woodward JG, Frelinger JG, Lord EM. "Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells." Immunology. 1999 May; 97(1):138-49.
1998 Oct
Wei C, Callahan BP, Turner MJ, Willis RA, Lord EM, Barth RK, Frelinger JG. "Regulation of human prostate-specific antigen gene expression in transgenic mice: evidence for an enhancer between the PSA and human glandular kallikrein-1 genes." International journal of molecular medicine. 1998 Oct; 2(4):487-96.
1998 Jun 15
Yeh KY, McAdam AJ, Pulaski BA, Shastri N, Frelinger JG, Lord EM. "IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes." The Journal of immunology : official journal of the American Association of Immunologists. 1998 Jun 15; 160(12):5773-80.
1998 May
Lord EM, Yeh KY, Moran JA, Storozynsky E, Frelinger JG. "IL-3-mediated enhancement of particulate antigen presentation by macrophages." Journal of immunotherapy. 1998 May; 21(3):205-10.
1998 Apr 1
Lee J, Fenton BM, Koch CJ, Frelinger JG, Lord EM. "Interleukin 2 expression by tumor cells alters both the immune response and the tumor microenvironment." Cancer research. 1998 Apr 1; 58(7):1478-85.
1998 Apr
Lord EM, Frelinger JG. "Tumor immunotherapy: cytokines and antigen presentation." Cancer immunology, immunotherapy : CII. 1998 Apr; 46(2):75-81.
1998 Feb
Willis RA, Wei C, Turner MJ, Callahan BP, Pugh AE, Barth RK, Lord EM, Frelinger JG. "A transgenic strategy for analyzing the regulatory regions of the human prostate-specific antigen gene: potential applications for the treatment of prostate cancer (Review)." International journal of molecular medicine. 1998 Feb; 1(2):379-86.
1997 Sep
Ostberg JR, Dragone LL, Borrello MA, Phipps RP, Barth RK, Frelinger JG. "Expression of mouse CD43 in the B cell lineage of transgenic mice causes impaired immune responses to T-independent antigens." European journal of immunology. 1997 Sep; 27(9):2152-9.
1997 Jun 10
Wei C, Willis RA, Tilton BR, Looney RJ, Lord EM, Barth RK, Frelinger JG. "Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy." Proceedings of the National Academy of Sciences of the United States of America. 1997 Jun 10; 94(12):6369-74.
1997 Apr 21
McEvoy LM, Sun H, Frelinger JG, Butcher EC. "Anti-CD43 inhibition of T cell homing." The Journal of experimental medicine. 1997 Apr 21; 185(8):1493-8.
1996 Jul
Wei C, Storozynsky E, McAdam AJ, Yeh KY, Tilton BR, Willis RA, Barth RK, Looney RJ, Lord EM, Frelinger JG. "Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes." Cancer immunology, immunotherapy : CII. 1996 Jul; 42(6):362-8.
1996 Apr 16
Pulaski BA, Yeh KY, Shastri N, Maltby KM, Penney DP, Lord EM, Frelinger JG. "Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells." Proceedings of the National Academy of Sciences of the United States of America. 1996 Apr 16; 93(8):3669-74.
1996
Ostberg JR, Dragone LL, Driskell T, Moynihan JA, Phipps R, Barth RK, Frelinger JG. "Disregulated expression of CD43 (leukosialin, sialophorin) in the B cell lineage leads to immunodeficiency." The Journal of immunology : official journal of the American Association of Immunologists. 1996 157(11):4876-84.
1995 Oct 15
McAdam AJ, Pulaski BA, Storozynsky E, Yeh KY, Sickel JZ, Frelinger JG, Lord EM. "Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor." Cellular immunology. 1995 Oct 15; 165(2):183-92.
1995 Oct 15
Yeh KY, Pulaski BA, Woods ML, McAdam AJ, Gaspari AA, Frelinger JG, Lord EM. "B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma." Cellular immunology. 1995 Oct 15; 165(2):217-24.
1995 May 29
McAdam AJ, Pulaski BA, Harkins SS, Hutter EK, Lord EM, Frelinger JG. "Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells." International journal of cancer. Journal international du cancer. 1995 May 29; 61(5):628-34.
1995 Jan 17
Dragone LL, Barth RK, Sitar KL, Disbrow GL, Frelinger JG. "Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival." Proceedings of the National Academy of Sciences of the United States of America. 1995 Jan 17; 92(2):626-30.
1994 Apr
McAdam AJ, Felcher A, Woods ML, Pulaski BA, Hutter EK, Frelinger JG, Lord EM. "Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes." Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy. 1994 Apr; 15(3):155-64.
1993 Nov
McAdam AJ, Yeh KY, Pulaski BA, Frelinger JG, Lord EM. "Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2." Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy. 1993 Nov; 14(4):293-7.
1993 May 1
Pulaski BA, McAdam AJ, Hutter EK, Biggar S, Lord EM, Frelinger JG. "Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism." Cancer research. 1993 May 1; 53(9):2112-7.
1993 Mar
Gaspari AA, Ferbel B, Frelinger JG. "Thy 1+ dendritic epidermal cells but not Langerhans cells express Ly 48." The Journal of investigative dermatology. 1993 Mar; 100(3):247-53.
1993
Baecher-Allan CM, Kemp JD, Dorfman KS, Barth RK, Frelinger JG. "Differential epitope expression of Ly-48 (mouse leukosialin)." Immunogenetics. 1993 37(3):183-92.
1993
Woods ML, McAdam AJ, Frelinger JG, Lord EM. "Isolation and expansion of tumor-infiltrating lymphocytes." BioTechniques. 1993 15(6):970-2.
1992 Sep
McAdam AJ, Blieden TM, Frelinger JG, Lord EM. "CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell clone." European journal of immunology. 1992 Sep; 22(9):2461-4.
1992 Feb 15
Cerosaletti KM, Woodward JG, Lord EM, Frelinger JG. "Two regions of the H-2 Dd promoter are responsive to dimethylsulfoxide in line 1 cells by a mechanism distinct from IFN-gamma." The Journal of immunology : official journal of the American Association of Immunologists. 1992 Feb 15; 148(4):1212-21.
1992
Dragone L, Pallant A, Insel R, Frelinger JG. "CD43 is expressed normally on Wiskott-Aldrich-derived lymphocytes." Experimental and clinical immunogenetics. 1992 9(3):130-40.
1991 Aug 15
Blieden TM, McAdam AJ, Frelinger JG, Lord EM. "Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor." The Journal of immunology : official journal of the American Association of Immunologists. 1991 Aug 15; 147(4):1433-8.
1991
Blieden TM, McAdam AJ, Foresman MD, Cerosaletti KM, Frelinger JG, Lord EM. "Class-I MHC expression in the mouse lung carcinoma, line 1: a model for class-I inducible tumors." International journal of cancer. Supplement = Journal international du cancer. Supplement. 1991 6:82-9.
1990 Aug 25
Dorfman KS, Litaker W, Baecher CM, Frelinger JG. "The nucleotide sequence of Ly 48 (mouse leukosialin, sialophorin): the mouse homolog of CD43." Nucleic acids research. 1990 Aug 25; 18(16):4932.
1990 Aug
Phipps RP, Baecher C, Frelinger JG, Penney DP, Keng P, Brown D. "Differential expression of interleukin 1 alpha by Thy-1+ and Thy-1- lung fibroblast subpopulations: enhancement of interleukin 1 alpha production by tumor necrosis factor-alpha." European journal of immunology. 1990 Aug; 20(8):1723-7.
1990 Jul
Pallant A, Fukuda M, Frelinger JG. "CD43 (leukosialin, sialophorin, large sialoglycoprotein) can be expressed in both normal and Wiskott-Aldrich fibroblasts via transfection of a leukosialin cDNA." European journal of immunology. 1990 Jul; 20(7):1423-8.
1990 May
Cerosaletti KM, Blieden TM, Harwell LW, Welsh KM, Frelinger JG, Lord EM. "Alteration of the metastatic potential of line 1 lung carcinoma cells: opposite effects of class I antigen induction by interferons versus DMSO or gene transfection." Cellular immunology. 1990 May; 127(2):299-310.
1990
Baecher CM, Dorfman KS, Mattei MG, Frelinger JG. "cDNA cloning and localization of the mouse leukosialin gene (Ly48) to chromosome 7." Immunogenetics. 1990 31(5-6):307-14.
1989 Feb
Pallant A, Eskenazi A, Mattei MG, Fournier RE, Carlsson SR, Fukuda M, Frelinger JG. "Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16." Proceedings of the National Academy of Sciences of the United States of America. 1989 Feb; 86(4):1328-32.
1988 Jun 1
Bahler DW, Cerosaletti KM, Lord EM, Frelinger JG. "Molecular analysis of deficient class I H-2 antigen expression by mouse lung carcinoma cells." The Journal of immunology : official journal of the American Association of Immunologists. 1988 Jun 1; 140(11):4003-12.
1988 Apr 1
Dennert G, Landon C, Lord EM, Bahler DW, Frelinger JG. "Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens." The Journal of immunology : official journal of the American Association of Immunologists. 1988 Apr 1; 140(7):2472-5.
1988
Baecher CM, Infante AJ, Semcheski KL, Frelinger JG. "Identification and characterization of a mouse cell surface antigen with alternative molecular forms." Immunogenetics. 1988 28(5):295-302.
1987 Jul
Bahler DW, Frelinger JG, Harwell LW, Lord EM. "Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection." Proceedings of the National Academy of Sciences of the United States of America. 1987 Jul; 84(13):4562-6.
1985 Oct
Sawicki JA, Frelinger JG, Palmer M, Buck DA, Dietzschold B, Wettstein PJ. "Identical RT1 class II molecules are expressed by rat RT1m and RT1c haplotypes." The Journal of immunology : official journal of the American Association of Immunologists. 1985 Oct; 135(4):2853-8.
1985 Jul
Frelinger JG, Shigeta M, Fathman CG. "An analysis of monoclonal T cell and antibody recognition sites on Ia molecules." The Journal of investigative dermatology. 1985 Jul; 85(1 Suppl):30s-33s.
1984 Oct
Frelinger J, Sing A, Infante A, Fathman CG. "Clonotypic antibodies which stimulate T cell clone proliferation." Immunological reviews. 1984 Oct; 81:21-38.
1984 Mar 1
Frelinger JG, Shigeta M, Infante AJ, Nelson PA, Pierres M, Fathman CG. "Multiple functional sites on a single Ia molecule defined using T cell clones and antibodies with chain-determined specificity." The Journal of experimental medicine. 1984 Mar 1; 159(3):704-15.
1983
Fathman CG, Frelinger JG. "T-lymphocyte clones." Annual review of immunology. 1983 1:633-55.
1982 Oct 1
Beck BN, Frelinger JG, Shigeta M, Infante AJ, Cummings D, Hämmerling G, Fathman CG. "T cell clones specific for hybrid I-A molecules. Discrimination with monoclonal anti-I-Ak antibodies." The Journal of experimental medicine. 1982 Oct 1; 156(4):1186-94.
1981 Sep
Steinmetz M, Moore KW, Frelinger JG, Sher BT, Shen FW, Boyse EA, Hood L. "A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains." Cell. 1981 Sep; 25(3):683-92.
1981 Jun
Frelinger JG, Hood L, Wettstein P. "Analyses of RT1 products using two-dimensional polyacrylamide gels." Transplantation proceedings. 1981 Jun; 13(2):1360-3.
1981 Jun
Wettstein PJ, Frelinger JG, Hood L. "Serologic and biochemical analyses of rat class II molecules with anti-Ia sera." Transplantation proceedings. 1981 Jun; 13(2):1364-6.
1981 Apr
Steinmetz M, Frelinger JG, Fisher D, Hunkapiller T, Pereira D, Weissman SM, Uehara H, Nathenson S, Hood L. "Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes." Cell. 1981 Apr; 24(1):125-34.
1981 Mar 1
Frelinger JG, Frelinger JA, Hood L. "Peptide map comparisons of epidermal and spleen H-2 molecules." Immunogenetics. 1981 Mar 1; 12(5-6):569-77.
1981
Wettstein PJ, Frelinger JG, Hood L. "Serological and biochemical characterization of rat (RT1) class II molecules with restricted mouse anti-Ia sera." Immunogenetics. 1981 13(1-2):93-107.
1980 Jul
Frelinger JA, Frelinger JG. "Bone marrow origin of Ia molecules purified from epidermal cells." The Journal of investigative dermatology. 1980 Jul; 75(1):68-70.
1980 Feb
Blankenhorn EP, Cecka JM, Frelinger J, Götze D, Hood L. "Structure of Ia antigens from the rat. Mouse alloantisera demonstrate at least two distinct molecular species." European journal of immunology. 1980 Feb; 10(2):145-51.
1979 Nov 15
Frelinger JG, Hood L, Hill S, Frelinger JA. "Mouse epidermal Ia molecules have a bone marrow origin." Nature. 1979 Nov 15; 282(5736):321-3.
1976 Oct
Frelinger JG, Motulsky H, Woodward DO. "Effects of Chloramphenicol on the Circadian Rhythm of Neurospora crassa." Plant physiology. 1976 Oct; 58(4):592-4.